Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.39
(
-1.30%
)
Bitcoin
81,106.26
(
0.76%
)
News Focus
News Focus

Replies to post #339934 on Elite Pharmaceuticals Inc (ELTP)

Replies to #339934 on Elite Pharmaceuticals Inc (ELTP)
icon url

senderos

07/28/20 8:09 AM

#339936 RE: Couch #339934

Wow. Welcome back Couch.
icon url

Dubster watching

07/28/20 9:04 AM

#339943 RE: Couch #339934

Bought out has been my hopes for this after all these years of treading water.

Hey Couch, long time no see. Glad to have you.
Dubster
icon url

NASDAQ2020

07/28/20 9:33 AM

#339948 RE: Couch #339934

Shout out to Couch and IQVIA !!!!!!!!!

ELTP
icon url

pgp419

07/28/20 9:43 AM

#339950 RE: Couch #339934

Couch, Welcome Back
icon url

littlerhody

07/28/20 9:57 AM

#339960 RE: Couch #339934

Welcome Back!
icon url

meshcan

07/28/20 10:23 AM

#339963 RE: Couch #339934

Welcome back Couch!
icon url

jour_trader

07/28/20 12:28 PM

#339982 RE: Couch #339934

What a surprise! Welcome back. Does this mean we’ll see Langston back as well?

Nice to see price climb today, but bid support on L2 is pretty thin to be back where we were yesterday.

Whether you look at revenue or potential near-term EBITDA multiples, Elite has a long way to go to fare well in an acquisition for shareholders. I think it will still be several years before anything like that takes place. We don’t have much insight to look at what 2021 revenues and beyond look like as well as the pipeline and ability to develop to the finish line.

Nasrat’s ownership could be sold outside an acquisition as we sometimes see significant owners cashing out in their company to a larger investor. I think about half of M&A life science acquisitions include a mgmt carveout to ensure management gets a sweet deal as well due for warrants/options and breathing. Something I have no doubt Nasrat will be sure to include.